dronabinol 5 mg

1 INDICATIONS AND USAGE DRONABINOL CAPSULES, USP are indicated in adults for the treatment of: • anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS). • nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. Dronabinol capsules are a cannabinoid indicated in adults for the treatment of: • Anorexia associated with weight loss in patients with AIDS. ( 1 ) • Nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. ( 1 )

Major Pharmaceuticals

FDA Reported Adverse Reactions
`[1] dyspnoea` `[2] drug ineffective` `[3] fatigue` `[4] nausea` `[5] off label use` `[6] headache` `[7] pain` `[8] diarrhoea` `[9] pneumonia` `[10] dizziness`

2 years ago

OVAL BROWN RP 868

16 HOW SUPPLIED/STORAGE AND HANDLING DRONABINOL capsuleS, USP are supplied as: 2.5 mg oblong opaque cream capsules (Identified as RP 867) Carton of 100 capsules (10 capsules each blister pack x 10) NDC 0904-6745-61 5 mg oblong opaque brown capsules (Identified as RP 868) Carton of 30 capsules (10 capsules each blister pack x 3) NDC0904-6746-04 Storage Conditions Dronabinol capsules, USP should be packaged in a well-closed container and stored in a refrigerator 2° to 8°C (36° to 46°F). Protect from freezing.

More pills like OVAL RP 868

Related Pills

dronabinol 2.5 mg

Major Pharmaceuticals

dronabinol capsule

rhodes pharmaceuticals l.p.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site